Niagen Bioscience (NAGE) Other Non-Current Liabilities (2011 - 2020)
Niagen Bioscience (NAGE) reported Other Non-Current Liabilities of $250000.0 for Q2 2020, down 14.68% year-over-year from $293000.0 in Q3 2019, and up 5.04% quarter-over-quarter from $238000.0 in Q1 2020.
Niagen Bioscience (NAGE) Other Non-Current Liabilities (2011 - 2020) Analysis & Trends
Niagen Bioscience (NAGE) has 8 years of Other Non-Current Liabilities data on file, last reported at $250000.0 in Q2 2020.
- Other Non-Current Liabilities for Q2 2020 came in at $250000.0, down 14.68% year-over-year; the trailing twelve-month figure through Jun 2020 was $250000.0 (down 14.68% YoY), and the FY2019 annual result was $169000.0, down 38.55% from the prior year.
- Other Non-Current Liabilities advanced to $250000.0 in Q2 2020 per NAGE's latest filing, from $238000.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $503850.0 in Q3 2017 and troughed at $155000.0 in Q3 2018.
- A 5-year average of $286329.8 and a median of $275000.0 in 2018 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2018 and 2019: Other Non-Current Liabilities slumped 63.28% in 2018, then jumped 79.7% in 2019.
- A 5-year view of Other Non-Current Liabilities shows it stood at $389010.0 in 2016, then decreased by 19.28% to $314000.0 in 2017, then decreased by 12.42% to $275000.0 in 2018, then tumbled by 38.55% to $169000.0 in 2019, then surged by 47.93% to $250000.0 in 2020.
- Business Quant data shows NAGE's Other Non-Current Liabilities at $250000.0 in Q2 2020, $238000.0 in Q1 2020, and $169000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Niagen Bioscience | 269.32 Mn | 202.77 Mn | 19.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 250,000.00 |
| Mar 31, 2020 | 238,000.00 |
| Dec 31, 2019 | 169,000.00 |
| Sep 30, 2019 | 261,000.00 |
| Jun 30, 2019 | 293,000.00 |
| Mar 31, 2019 | 363,000.00 |
| Dec 31, 2018 | 275,000.00 |
| Sep 30, 2018 | 155,000.00 |
| Jun 30, 2018 | 185,000.00 |
| Mar 31, 2018 | 202,000.00 |
| Dec 30, 2017 | 314,000.00 |
| Sep 30, 2017 | 321,119.00 |
| Jul 1, 2017 | 503,850.00 |
| Apr 1, 2017 | 399,010.00 |
| Dec 31, 2016 | 389,010.00 |
| Oct 1, 2016 | 277,615.00 |
| Jan 2, 2016 | 272,002.00 |
| Mar 30, 2013 | 314,468.00 |
| Dec 29, 2012 | 310,267.00 |
| Sep 29, 2012 | 257,004.00 |